TLC590

DRUG5 trials

Sponsors

Taiwan Liposome Company, TLC Biopharmaceuticals, Inc.

Conditions

Hallux ValgusInguinal HerniaPostoperative PainPostsurgical Pain Management

Phase 1

Phase I/II Dose-escalation Study to Evaluate Safety, PK and Efficacy of TLC590 for Postsurgical Pain Management

CompletedNCT03591146

Taiwan Liposome CompanyInguinal Hernia

Start: 2018-07-31End: 2019-01-14Updated: 2021-07-14

Phase 2

A Study to Evaluate Safety, PK, Efficacy of TLC590 for Postsurgical Pain Management Following Bunionectomy

CompletedNCT03838133

Taiwan Liposome CompanyHallux Valgus

Start: 2019-03-05End: 2020-03-31Updated: 2020-04-07

Phase 2/3 Study of TLC590 for Postsurgical Pain Management

Not yet recruitingNCT05161637

Taiwan Liposome CompanyPostsurgical Pain Management

Start: 2025-04-30End: 2025-12-31Target: 415Updated: 2024-04-11

A Study on TLC590 for Managing Postsurgical Pain

RecruitingNCT06574269

TLC Biopharmaceuticals, Inc.Postsurgical Pain Management

Start: 2024-09-30End: 2026-08-31Target: 120Updated: 2025-12-02

Phase 3

A Study of TLC590 for Postsurgical Pain Following Bunionectomy

RecruitingNCT07222748

TLC Biopharmaceuticals, Inc.Postoperative Pain

Start: 2025-11-17End: 2026-05-31Target: 300Updated: 2025-12-02